全文获取类型
收费全文 | 4272346篇 |
免费 | 373010篇 |
国内免费 | 15359篇 |
专业分类
耳鼻咽喉 | 61587篇 |
儿科学 | 133436篇 |
妇产科学 | 112539篇 |
基础医学 | 651991篇 |
口腔科学 | 120785篇 |
临床医学 | 396736篇 |
内科学 | 771895篇 |
皮肤病学 | 104973篇 |
神经病学 | 369244篇 |
特种医学 | 171219篇 |
外国民族医学 | 912篇 |
外科学 | 655979篇 |
综合类 | 125805篇 |
现状与发展 | 58篇 |
一般理论 | 2577篇 |
预防医学 | 361390篇 |
眼科学 | 101394篇 |
药学 | 301233篇 |
19篇 | |
中国医学 | 11351篇 |
肿瘤学 | 205592篇 |
出版年
2021年 | 55307篇 |
2020年 | 37495篇 |
2019年 | 59127篇 |
2018年 | 76012篇 |
2017年 | 58781篇 |
2016年 | 65211篇 |
2015年 | 78427篇 |
2014年 | 114000篇 |
2013年 | 179652篇 |
2012年 | 118402篇 |
2011年 | 121401篇 |
2010年 | 125372篇 |
2009年 | 129462篇 |
2008年 | 108572篇 |
2007年 | 114622篇 |
2006年 | 124509篇 |
2005年 | 119237篇 |
2004年 | 119934篇 |
2003年 | 110637篇 |
2002年 | 101186篇 |
2001年 | 154897篇 |
2000年 | 150762篇 |
1999年 | 140070篇 |
1998年 | 72052篇 |
1997年 | 68356篇 |
1996年 | 66178篇 |
1995年 | 61872篇 |
1994年 | 55362篇 |
1993年 | 51383篇 |
1992年 | 103313篇 |
1991年 | 98989篇 |
1990年 | 94022篇 |
1989年 | 91558篇 |
1988年 | 85111篇 |
1987年 | 83640篇 |
1986年 | 79319篇 |
1985年 | 77769篇 |
1984年 | 65653篇 |
1983年 | 58459篇 |
1982年 | 47701篇 |
1981年 | 44445篇 |
1980年 | 41707篇 |
1979年 | 57468篇 |
1978年 | 46699篇 |
1977年 | 41160篇 |
1976年 | 38284篇 |
1975年 | 37528篇 |
1974年 | 42181篇 |
1973年 | 40354篇 |
1972年 | 37924篇 |
排序方式: 共有10000条查询结果,搜索用时 968 毫秒
961.
962.
Yu-Tzu Chan Alan C.-Y. Lai Ruey-Jen Lin Ya-Hui Wang Yi-Ting Wang Wen-Wei Chang Hsin-Yi Wu Yu-Ju Lin Wen-Ying Chang Jen-Chine Wu Jyh-Cherng Yu Yu-Ju Chen Alice L. Yu 《International journal of cancer. Journal international du cancer》2020,146(6):1674-1685
G protein-coupled estrogen receptor-1 (GPER), a member of the G protein-coupled receptor (GPCR) superfamily, mediates estrogen-induced proliferation of normal and malignant breast epithelial cells. However, its role in breast cancer stem cells (BCSCs) remains unclear. Here we showed greater expression of GPER in BCSCs than non-BCSCs of three patient-derived xenografts of ER−/PR+ breast cancers. GPER silencing reduced stemness features of BCSCs as reflected by reduced mammosphere forming capacity in vitro, and tumor growth in vivo with decreased BCSC populations. Comparative phosphoproteomics revealed greater GPER-mediated PKA/BAD signaling in BCSCs. Activation of GPER by its ligands, including tamoxifen (TMX), induced phosphorylation of PKA and BAD-Ser118 to sustain BCSC characteristics. Transfection with a dominant-negative mutant BAD (Ser118Ala) led to reduced cell survival. Taken together, GPER and its downstream signaling play a key role in maintaining the stemness of BCSCs, suggesting that GPER is a potential therapeutic target for eradicating BCSCs. 相似文献
963.
Tianjiao Lyu Yahui Jiang Nan Jia Xiaoxia Che Qin Li Yinhua Yu Keqin Hua Robert C. Bast Jr Weiwei Feng 《International journal of cancer. Journal international du cancer》2020,146(6):1553-1567
Detachment of cancer cells from the primary tumor and formation of spheroids in ascites is required for implantation metastasis in epithelial ovarian cancer (EOC), but the underlying mechanism of this process has not been thoroughly elucidated. To mimic this process, ovarian cancer cells were grown in 3D and 2D culture. Hey and OVCA433 spheroids exhibited decreased cell proliferation and enhanced adhesion and invasion. SMYD3 expression was elevated in ovarian carcinoma spheroids in association with increased H3K4 methylation. Depletion of SMYD3 by transient siRNA, stable shRNA knockdown and the SMYD3 inhibitor BCI-121 all decreased spheroid invasion and adhesion. Gene expression arrays revealed downregulation of integrin family members. Inhibition assays confirmed that invasion and adhesion of spheroids are mediated by ITGB6 and ITGAM. SMYD3-deficient cells regained the ability to invade and adhere after forced overexpression of SMYD3, ITGB6 and ITGAM. However, this biological ability was not restored by forced overexpression of SMYD3 in ITGB6- and/or ITGAM-deficient cancer cells. SMYD3 and H3K4me3 binding at the ITGB6 and ITGAM promoters was increased in spheroids compared to that in monolayer cells, and the binding was decreased when SMYD3 expression was inhibited, consistent with the expression changes in integrins. SMYD3 expression and integrin-mediated adhesion were also activated in an intraperitoneal xenograft model and in EOC patient spheroids. In vivo, SMYD3 knockdown inhibited tumor metastasis and reduced ascites volume in both the intraperitoneal xenograft model and a PDX model. Overall, our results suggest that the SMYD3-H3K4me3-integrin pathway plays a crucial role in ovarian cancer metastasis to the peritoneal surface. 相似文献
964.
965.
966.
967.
968.
Journal of Neuro-Oncology - 相似文献
969.
C. M. de Bont N. Eerden W. C. Boelens G. J. M. Pruijn 《Clinical and experimental immunology》2020,199(1):1-8
Neutrophils can form neutrophil extracellular traps (NETs) to capture microbes and facilitate their clearance. NETs consist of decondensed chromatin decorated with anti-microbial proteins. Here, we describe the effect of neutrophil proteases on the protein content of NETs. We show that the neutrophil serine proteases degrade several neutrophil proteins associated with NETs. Interestingly, the anti-bacterial proteins associated with NETs, such as myeloperoxidase, calgranulin B and neutrophil elastase (NE), seem to be less susceptible to proteolytic degradation than other NET proteins, such as actin and MNDA. NETs have been proposed to play a role in autoimmune reactions. Our data demonstrate that a large number of the autoepitopes of NET proteins that are recognized by autoantibodies produced by systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients are also removed by the proteases. In conclusion, neutrophil serine proteases have a major impact on the NET proteome and the proteolytic changes of NET-associated proteins may counteract autoimmune reactions to NET components. 相似文献
970.
Nicola Flaum Emma J. Crosbie Richard J. Edmondson Miriam J. Smith Dafydd G. Evans 《Clinical genetics》2020,97(1):54-63
Ovarian cancer is the fourth most common cause of cancer-related death in women in the developed world, and one of the most heritable cancers. One of the most significant risk factors for epithelial ovarian cancer (EOC) is a family history of breast and/or ovarian cancer. Combined risk factors can be used in models to stratify risk of EOC, and aid in decisions regarding risk-reduction strategies. Germline pathogenic variants in EOC susceptibility genes including those involved in homologous recombination and mismatch repair pathways are present in approximately 22% to 25% of EOC. These genes are associated with an estimated lifetime risk of EOC of 13% to 60% for BRCA1 variants and 10% to 25% for BRCA2 variants, with lower risks associated with remaining genes. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) thought to explain an additional 6.4% of the familial risk of ovarian cancer, with 34 susceptibility loci identified to date. However, an unknown proportion of the genetic component of EOC risk remains unexplained. This review comprises an overview of individual genes and SNPs suspected to contribute to risk of EOC, and discusses use of a polygenic risk score to predict individual cancer risk more accurately. 相似文献